Cargando…

Costs of Cancer Care Across the Disease Continuum

PURPOSE. The aim of this study was to estimate Medicare payments for cancer care during the initial, continuing, and end‐of‐life phases of care for 10 malignancies and to examine variation in expenditures according to patient characteristics and cancer severity. MATERIALS AND METHODS. We used linked...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaye, Deborah R., Min, Hye Sung, Herrel, Lindsey A., Dupree, James M., Ellimoottil, Chad, Miller, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AlphaMed Press 2018
Materias:	Health Outcomes and Economics of Cancer Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058326/ https://www.ncbi.nlm.nih.gov/pubmed/29567821 http://dx.doi.org/10.1634/theoncologist.2017-0481

Ejemplares similares

Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States
por: Copher, Ronda, et al.
Publicado: (2022)

Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)
por: McArthur, Grant A., et al.
Publicado: (2017)

The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors
por: George, Saby, et al.
Publicado: (2021)

Real‐World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B‐Cell Lymphoma in the U.S
por: Yang, Xiaoqin, et al.
Publicado: (2021)

Improved Survival of Young Adults with Cancer Following the Passage of the Affordable Care Act
por: Roth, Michael, et al.
Publicado: (2022)

Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data
por: Raphael, Jacques, et al.
Publicado: (2022)

Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
por: Choi, Jin G., et al.
Publicado: (2018)

Women Who Are Young, Non‐White, and with Lower Socioeconomic Status Report Higher Financial Toxicity up to 1 Year After Breast Cancer Surgery: A Mixed‐Effects Regression Analysis
por: Politi, Mary C., et al.
Publicado: (2020)

Individual Trade‐Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma
por: Postmus, Douwe, et al.
Publicado: (2017)

Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment
por: Ludwig, Heinz, et al.
Publicado: (2020)

Real‐World Clinical and Economic Outcomes in Selected Immune‐Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors
por: Zheng, Ying, et al.
Publicado: (2021)

Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta‐Analysis
por: Nielson, Carrie M., et al.
Publicado: (2021)

COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry
por: Borno, Hala T, et al.
Publicado: (2022)

“Game Changer”: Health Professionals’ Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management
por: Shickh, Salma, et al.
Publicado: (2022)

Temporal Trends in Inpatient Oncology Census Before and During the COVID‐19 Pandemic and Rates of Nosocomial COVID‐19 Among Patients with Cancer at a Large Academic Center
por: Zubiri, Leyre, et al.
Publicado: (2021)

Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID‐19
por: Klein, Isaac A., et al.
Publicado: (2021)

Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer
por: Tan, Ruoding, et al.
Publicado: (2022)

Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective
por: Azoulay, Laurent
Publicado: (2022)

Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum
por: Lai-Kwon, Julia, et al.
Publicado: (2022)

Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
por: Mitchell, Aaron P, et al.
Publicado: (2022)

Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda
por: Kizub, Darya A, et al.
Publicado: (2022)

The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer
por: Bhatt, Sunil, et al.
Publicado: (2022)

Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial
por: Gupta, Arjun, et al.
Publicado: (2023)

The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research
por: Flick, E Dawn, et al.
Publicado: (2023)

Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020
por: Perera, Nirosha D, et al.
Publicado: (2023)

Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups
por: Carter, Hannah Elizabeth, et al.
Publicado: (2019)

Variability in the Initial Costs of Care and One-Year Outcomes of Observation Services
por: Abbass, Ibrahim
Publicado: (2015)

Estimating the Cost of Care for Emergency Department Syncope Patients: Comparison of Three Models
por: Probst, Marc A., et al.
Publicado: (2017)

Cost-effectiveness of conditional cash transfers to retain women in the continuum of care during pregnancy, birth and the postnatal period: protocol for an economic evaluation of the Afya trial in Kenya
por: Batura, Neha, et al.
Publicado: (2019)

Age-adjusted and Expanded Lactate Thresholds as Predictors of All-Cause Mortality in the Emergency Department
por: Cannon, Chad M., et al.
Publicado: (2020)

Cost-effectiveness of chiropractic care versus self-management in patients with musculoskeletal chest pain
por: Stochkendahl, Mette Jensen, et al.
Publicado: (2016)

Sports-related traumatic brain injuries and acute care costs in children
por: Singh, Sonia, et al.
Publicado: (2023)

Homecare and Healthcare Utilization Errors Post–Neonatal Intensive Care Unit Discharge
por: Patel, Rupalee, et al.
Publicado: (2017)

Association of Age, Systolic Blood Pressure, and Heart Rate with Adult Morbidity and Mortality after Urgent Care Visits
por: Hart, James, et al.
Publicado: (2016)

Incorporating social network effects into cost-effectiveness analysis: a methodological contribution with application to obesity prevention
por: Konchak, Chad, et al.
Publicado: (2012)

Shared care versus hospital-based cardiac rehabilitation: a cost-utility analysis based on a randomised controlled trial
por: Bertelsen, Jannik B, et al.
Publicado: (2018)

In primary care, is measuring free-thyroxine plus thyroid-stimulating hormone to detect hypopituitarism cost-effective? A cost utility analysis using Markov chain models
por: Shine, Brian, et al.
Publicado: (2019)

A Prospective Study on the Incidence and Outcomes of Neonatal Thrombocytopenia at a Tertiary Care Facility in Central Saudi Arabia
por: Eltawel, Mohamed, et al.
Publicado: (2018)

End‐of‐Life Care Matters: Palliative Cancer Care Results in Better Care and Lower Costs
por: Dalal, Shalini, et al.
Publicado: (2017)

Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial)
por: Panca, Monica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kpgkkpr1b91dasvrlho64otges